Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00017079
DRKS00017079
Recruiting
Not Applicable

Quantitative EEG as biomarker for the prediction of seizures, depression and cognitive decline after stroke - A substudy to the Berling Longterm Observation of Vascular Events - BeLOVE - Study

Charité Campus Benjamin Franklin0 sites625 target enrollmentMay 15, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsI63.9G40.9Cerebral infarction, unspecifiedEpilepsy, unspecified

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
I63.9
Sponsor
Charité Campus Benjamin Franklin
Enrollment
625
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 15, 2019
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Charité Campus Benjamin Franklin

Eligibility Criteria

Inclusion Criteria

  • •acute cerebrovascular disorders (trigger event), defined by:
  • •i) a transient ischemic attack (TIA) with clinical restitution within 24h AND
  • •initial neurological deficit verified by a neurologist OR ABCD2\-Score \>\= 3 OR
  • •visibleDWI\-lesion (MRI) OR the main hospital diagnosis of Amaurosis fugax
  • •ii) Ischemic stroke including retinal central artery occlusion
  • •iii) stroke caused by non\-traumatic intracerebral hemorrhage
  • •iv) stroke caused by cerebral venous thrombosis

Exclusion Criteria

  • •Epileptic seizure prior to the event leading to inclusion in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 1
Is Quantitative Electroencephalography useful in predicting treatment outcome in patients with bipolar affective disorder currently having manic symptoms?Health Condition 1: F311- Bipolar disorder, current episodemanic without psychotic features
CTRI/2020/02/023566Department of psychiatry Government medical college and hospital sector Chandigarh
Not yet recruiting
Phase 4
sing a test called QEEG i.e. quantitative electroencephalogram to check the response to clozapine in patients of schizophrenia with no response on multiple medications previously.
CTRI/2023/09/058046Government medical college and hospital sector 32
Completed
Not Applicable
Electroencephalogram (EEG) and Electroconvulsive Therapy(ECT) Response in SchizophreniaSchizophrenia
NCT04220099Shanghai Mental Health Center30
Not yet recruiting
Not Applicable
Role of Neuron Specific Enolase in prognostication of Traumatic Brain Injury and Ischaemic Brain InjuryHealth Condition 1: G936- Cerebral edema
CTRI/2024/07/071047Medicover Hospitals
Not yet recruiting
Not Applicable
Brain function of people with depressive symptoms before and after tDCS, tPCS and cognitive rehabilitation interventions
IRCT20230922059489N1Ferdowsi University of Mashhad60